SCHEMBL1111544

SCHEMBL1111544

OC[C@H]1OC[C@@H](O)[C@@H](O)[C]1O

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.33
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1766044 1.00 THRB (0.33) THRBLMNA
SCHEMBL17363879 1.00 THRB (0.33) THRBLMNA
SCHEMBL22615899 1.00 THRB (0.33) THRBLMNA
SCHEMBL27796917 1.00 THRB (0.33) THRBLMNA
1,5-Anhydrosorbitol SCHEMBL28064228 0.88 TREH (0.37) LMNA
SCHEMBL28310370 0.77
SCHEMBL4423849 0.77
SCHEMBL9006292 0.77
SCHEMBL27305933 0.77 LMNA (0.32) THRBLMNA
SCHEMBL25263049 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4262728-A1 ANTI-DANDRUFF COMPOSITION COMPRISING PIROCTONE OLAMINE Unilever IP Holdings B.V. (NL) 2023-10-25 EP disclosed
WO-2022128551-A1 ANTI-DANDRUFF COMPOSITION COMPRISING PIROCTONE OLAMINE UNILEVER IP HOLDINGS B.V. (NL) 2022-06-23 WO disclosed
EP-2661266-A2 CHEMOSENSORY RECEPTOR LIGAND-BASED THERAPIES Elcelyx Therapeutics, Inc. (US) 2013-11-13 EP disclosed
EP-2566447-A2 STABILIZED OPHTHALMIC GALACTOMANNAN FORMULATIONS Alcon Research, Ltd. (US) 2013-03-13 EP disclosed
EP-2506831-A2 CARBOXYVINYL POLYMER-CONTAINING NANOPARTICLE SUSPENSION Alcon Research, Ltd. (US) 2012-10-10 EP disclosed
WO-2012094636-A2 CHEMOSENSORY RECEPTOR LIGAND-BASED THERAPIES ELCELYX THERAPEUTICS, INC. (US) 2012-07-12 WO disclosed
WO-2011140203-A2 STABILIZED OPHTHALMIC GALACTOMANNAN FORMULATIONS ALCON RESEARCH, LTD. (US) 2011-11-10 WO disclosed
WO-2011068872-A2 CARBOXYVINYL POLYMER-CONTAINING NANOPARTICLE SUSPENSION ALCON RESEARCH, LTD. (US) 2011-06-09 WO disclosed
EP-2278954-A1 POLYMERIC ARTIFICIAL TEAR SYSTEM Alcon Research, Ltd. (US) 2011-02-02 EP disclosed
WO-2009132294-A1 POLYMERIC ARTIFICIAL TEAR SYSTEM ALCON RESEARCH, LTD. (US) 2009-10-29 WO disclosed
WO-2002072687-A2 PHYSICAL FORMS OF CLARIFIED HYDROCOLLOIDS OF UNDIMINISHED PROPERTIES AND METHOD OF PRODUCING SAME MARINE BIOPRODUCTS INTERNATIONAL (CA) 2002-09-19 WO disclosed
EP-0999854-A1 SWITCHABLE VISCOELASTIC SYSTEMS CONTAINING GALACTOMANNAN POLYMERS AND BORATE ALCON LABORATORIES, INC. (US) 2000-05-17 EP disclosed
EP-0999825-A1 OPHTHALMIC COMPOSITIONS CONTAINING GALACTOMANNAN POLYMERS AND BORATE ALCON LABORATORIES, INC. (US) 2000-05-17 EP disclosed
EP-0970175-A1 CONDITIONING SOLUTIONS FOR HARD CONTACT LENS CARE ALCON LABORATORIES, INC. (US) 2000-01-12 EP disclosed
WO-1999006070-A9 SWITCHABLE VISCOELASTIC SYSTEMS CONTAINING GALACTOMANNAN POLYMERS AND BORATE ALCON LAB INC (US) 1999-04-29 WO disclosed
WO-1999006070-A1 SWITCHABLE VISCOELASTIC SYSTEMS CONTAINING GALACTOMANNAN POLYMERS AND BORATE ALCON LABORATORIES, INC. (US) 1999-02-11 WO disclosed
WO-1999006512-A1 CONDITIONING SOLUTIONS FOR HARD CONTACT LENS CARE ALCON LABORATORIES, INC. (US) 1999-02-11 WO disclosed
WO-1999006023-A1 OPHTHALMIC COMPOSITIONS CONTAINING GALACTOMANNAN POLYMERS AND BORATE ALCON LABORATORIES, INC. (US) 1999-02-11 WO disclosed
EP-0233837-A2 Saccharide derivatives and method for their preparation CIBA-GEIGY AG (CH) 1987-08-26 EP disclosed